How the Human Brain Repairs Itself | Ask a Professor

A new development in a Georgetown lab could revolutionize the treatment for patients with late-stage multiple sclerosis and slow the progression of the disease.
Jeffrey Huang, a provost’s distinguished associate professor in the College of Arts & Sciences’ Department of Biology, and his team have developed a new drug that reversed the effects of late-stage MS in mice. The drug is now being planned for a clinical trial on people with MS.
“Our team is ecstatic to move to clinical trials,” said Huang. “Based on our success in animal trials, we believe our drug will help stabilize patients with the disease, reducing not only the number of relapses, but their severity as well.”
Read the full story: bit.ly/3tIgYu8

[@Clay_Tucker]

Don't waste 2:58, they do not tell you the name of the compound.

[@user255]

Do you think that is the reason people watch this?
Drug that works in mice, works very rarely on humans. Also, even if it works, it might be very far from being accessible without approval.